Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eucommia ulmoides capsule for 24-hour blood pressure rhythm in essential hypertension
ChiCTR2100046830Phase 4Recruiting
- Sponsor
- Institute of Basic Theory of Chinese Medicine
- Start
- Dec 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Eucommia ulmoides bark in essential hypertension (2 arms), sponsored by Institute of Basic Theory of Chinese Medicine. Primary endpoints: Spoon (dipper) blood pressure recovery rate, Blood pressure variability index and 1 more. Started Dec 2020; status: recruiting.
02
Drugs
Eucommia ulmoides bark
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2100046830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046830.